1. Academic Validation
  2. Piceatannol and Pumpkin Seed Oil Synergistically Promote Apoptosis of PC3 Prostate Cancer Cells via Intrinsic Mitochondrial Pathway

Piceatannol and Pumpkin Seed Oil Synergistically Promote Apoptosis of PC3 Prostate Cancer Cells via Intrinsic Mitochondrial Pathway

  • ACS Omega. 2025 Nov 3;10(44):52202-52214. doi: 10.1021/acsomega.4c11639.
Mohammed Z Nasrullah 1 Lenah S Binmahfouz 1 Amina M Bagher 1 Rawan H Hareeri 1 Hawazen H Bin-Melaih 2 Osama A Abuzinadah 2 Azizah M Malebari 3 Ashraf B Abdel-Naim 1 Thikryat Neamatallah 1
Affiliations

Affiliations

  • 1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • 2 Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • 3 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abstract

Purpose: Piceatannol (PIC) is a polyphenolic stilbene that occurs naturally in various fruits and vegetables. Despite its well-documented Anticancer activity, PIC has poor pharmacokinetic properties. Pumpkin seed oil (PSO) has well-known antiproliferative activities on prostate cells. This study aimed to enhance the cytotoxicity of PIC in PC3 prostate adenocarcinoma cells by incorporating PIC into a PSO-based self-emulsifying drug delivery system (PIC-PSO SEDDS). Methods: PIC solubility was investigated along with PSO. Then, the percentage of selected components used in the formulation was optimized to achieve minimum globule size. Results: The optimized PIC-PSO SEDDS was evaluated for its cytotoxicity, cell cycle distribution, apoptotic activities, Reactive Oxygen Species (ROS), and mitochondrial membrane potential (MMP) in PC3 cells. The optimized formula exhibited a globule size of 576.00 ± 39.74 nm. PC3 cells treated with PIC-loaded PSO SEDDS had considerably higher antiproliferative activity than PIC, with an IC50 value of 6.37 ± 0.41 μM. Combination index analysis revealed strong synergistic interactions between PIC and PSO, with a value of 0.24. PIC-PSO SEDDS also caused considerable G2 arrest by downregulating CDK1 mRNA expression. In addition, the formulation significantly increased the apoptotic cell percentage, increased Caspase-3 concentration, upregulated Bax, and CYCS mRNA expression, and downregulated BCL2 mRNA expression. These effects were associated with enhanced generation of ROS and a decrease in MMP. Conclusion: Based on these results, incorporating PIC into PSO-based SEDDS improves its pro-apoptotic activity against PC3 cells. This involves, at least partly, induction of the intrinsic mitochondrial Apoptosis pathway.

Figures
Products